Ability of IDO to attenuate liver injury in α-galactosylceramide- induced hepatitis model

Journal of Immunology

Volumn 185, Issue 8, 2010, Pages 4554-4560

  Ito, Hiroyasu ^a   Hoshi, Masato ^a   Ohtaki, Hirofumi ^a   Taguchi, Ayako ^a   Ando, Kazuki ^a,b   Ishikawa, Tetsuya ^c   Osawa, Yosuke ^a   Hara, Akira ^a   Moriwaki, Hisataka ^a   Saito, Kuniaki ^d   Seishima, Mitsuru ^a  

^a GIFU UNIVERSITY   (Japan)

^b Goto Clinic   (Japan)

^c Nagoya Kyoritsu Hospital   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALPHA2 INTEGRIN; CD11B ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; MESSENGER RNA; N METHYLTRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; ALPHA-GALACTOSYLCERAMIDE; CYTOKINE; GALACTOSYLCERAMIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FLOW CYTOMETRY; HEPATITIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIVER INJURY; LYMPHOCYTE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL SEPARATION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INJURY; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; CELL SEPARATION; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; HEPATITIS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78049522618     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904173     Document Type: Article

References (26)

1. Munn, D. H., E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and A. L. Mellor. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189:1363-1372.
2. Mellor, A. L., and D. H. Munn. 1999. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol. Today 20:469-473.
3. Taylor, M. W., and G. S. Feng. 1991. Relationship between interferon-g, indoleamine 2, 3-dioxygenase, and tryptophan catabolism. FASEB J. 5:2516-2522.
4. Fujigaki, S., K. Saito, K. Sekikawa, S. Tone, O. Takikawa, H. Fujii, H. Wada, A. Noma, and M. Seishima. 2001. Lipopolysaccharide induction of indoleamine 2, 3-dioxygenase is mediated dominantly by an IFN-γ- independent mechanism. Eur. J. Immunol. 31:2313-2318.
5. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M. L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4:1206-1212.
6. Grohmann, U., F. Fallarino, R. Bianchi, C. Orabona, C. Vacca, M. C. Fioretti, and P. Puccetti. 2003. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J. Exp. Med. 198:153-160.
7. Terness, P., T. M. Bauer, L. Röse, C. Dufter, A. Watzlik, H. Simon, and G. Opelz. 2002. Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenaseexpressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196:447-457.
8. Iwamoto, N., H. Ito, K. Ando, T. Ishikawa, A. Hara, A. Taguchi, K. Saito, M. Takemura, M. Imawari, H. Moriwaki, and M. Seishima. 2009. Upregulation of indoleamine 2, 3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo. Liver Int. 29:277-283.
9. Larrea, E., J. I. Riezu-Boj, L. Gil-Guerrero, N. Casares, R. Aldabe, P. Sarobe, M. P. Civeira, J. L. Heeney, C. Rollier, B. Verstrepen, et al. 2007. Upregulation of indoleamine 2, 3-dioxygenase in hepatitis C virus infection. J. Virol. 81:3662-3666.
10. Biburger, M., and G. Tiegs. 2008. Activation-induced NKT cell hyporesponsiveness protects from α-galactosylceramide hepatitis and is independent of active transregulatory factors. J. Leukoc. Biol. 84:264-279.
11. Nakagawa, R., I. Nagafune, Y. Tazunoki, H. Ehara, H. Tomura, R. Iijima, K. Motoki, M. Kamishohara, and S. Seki. 2001. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α- galactosylceramide in mice. J. Immunol. 166:6578-6584.
12. Biburger, M., and G. Tiegs. 2005. α-Galactosylceramide-induced liver injury in mice is mediated by TNF-α but independent of Kupffer cells. J. Immunol. 175:1540-1550.
13. Hoshi, M., H. Ito, H. Fujigaki, M. Takemura, T. Takahashi, E. Tomita, M. Ohyama, R. Tanaka, K. Saito, and M. Seishima. 2009. Indoleamine 2, 3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity. Leuk. Res. 33:39-45.
14. Ito, H., K. Ando, T. Ishikawa, K. Saito, M. Takemura, M. Imawari, H. Moriwaki, and M. Seishima. 2009. Role of TNF-α produced by nonantigen-specific cells in a fulminant hepatitis mouse model. J. Immunol. 182:391-397.
15. Ito, H., K. Ando, T. Nakayama, M. Taniguchi, T. Ezaki, K. Saito, M. Takemura, K. Sekikawa, M. Imawari, M. Seishima, and H. Moriwaki. 2003. Role of Vα14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology 38:1116-1124.
16. Godfrey, D. I., K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21:573-583.
17. + NKT cells promotes the breakage of CTL tolerance. Int. Immunol. 20:869-879.
18. Wintermeyer, P., C. W. Cheng, S. Gehring, B. L. Hoffman, M. Holub, L. Brossay, and S. H. Gregory. 2009. Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage. Gastroenterology 136:1048-1059.
19. Harrington, L., C. V. Srikanth, R. Antony, S. J. Rhee, A. L. Mellor, H. N. Shi, and B. J. Cherayil. 2008. Deficiency of indoleamine 2, 3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis. Infect. Immun. 76:3045-3053.
20. Mohib, K., S. Wang, Q. Guan, A. L. Mellor, H. Sun, C. Du, and A. M. Jevnikar. 2008. Indoleamine 2, 3-dioxygenase expression promotes renal ischemiareperfusion injury. Am. J. Physiol. Renal Physiol. 295: F226-F234.
21. Scott, G. N., J. DuHadaway, E. Pigott, N. Ridge, G. C. Prendergast, A. J. Muller, and L. Mandik-Nayak. 2009. The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity. J. Immunol. 182:7509-7517.
22. Minagawa, M., Q. Deng, Z. X. Liu, H. Tsukamoto, and G. Dennert. 2004. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-α during alcohol consumption. Gastroenterology 126:1387-1399.
23. Inui, T., H. Nakashima, Y. Habu, R. Nakagawa, M. Fukasawa, M. Kinoshita, N. Shinomiya, and S. Seki. 2005. Neutralization of tumor necrosis factor abrogates hepatic failure induced by α-galactosylceramide without attenuating its antitumor effect in aged mice. J. Hepatol. 43:670-678.
24. Shimizu, K., A. Goto, M. Fukui, M. Taniguchi, and S. Fujii. 2007. Tumor cells loaded with α-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice. J. Immunol. 178:2853-2861.
25. Frumento, G., R. Rotondo, M. Tonetti, G. Damonte, U. Benatti, and G. B. Ferrara. 2002. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase. J. Exp. Med. 196:459-468.
26. Sarkhosh, K., E. E. Tredget, A. Karami, H. Uludag, T. Iwashina, R. T. Kilani, and A. Ghahary. 2003. Immune cell proliferation is suppressed by the interferon-γ-induced indoleamine 2, 3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG). J. Cell. Biochem. 90:206-217.